DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Fispemifene is an investigational drug.
There have been 4 clinical trials for Fispemifene. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2015.
The most common disease conditions in clinical trials are Hypogonadism, Erectile Dysfunction, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are QuatRx Pharmaceuticals Company, Hormos Medical, and NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.).
There are forty-one US patents protecting this investigational drug and nine hundred and eighty-four international patents.
Recent Clinical Trials for Fispemifene
|Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men||NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)||Phase 2|
|Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy||QuatRx Pharmaceuticals Company||Phase 2|
|Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors||Hormos Medical||Phase 2|
Top disease conditions for Fispemifene
Top clinical trial sponsors for Fispemifene
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Fispemifene||⤷ Sign up for a Free Trial||Selective androgen receptor modulator and methods of use thereof||UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, TN)||⤷ Sign up for a Free Trial|
|Fispemifene||⤷ Sign up for a Free Trial||Methods for immunomodulation of cancer and infectious disease therapy||The Regents of the University of California (Oakland, CA)||⤷ Sign up for a Free Trial|
|Fispemifene||⤷ Sign up for a Free Trial||Molecules for administration to ROS1 mutant cancer cells||IGNYTA, INC. (San Diego, CA) NERVIANO MEDICAL SCIENCES S.R.L. (Nerviano, IT)||⤷ Sign up for a Free Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Fispemifene||Argentina||AR061980||2024-06-07||⤷ Sign up for a Free Trial|
|Fispemifene||Argentina||AR062536||2024-06-07||⤷ Sign up for a Free Trial|
|Fispemifene||Austria||AT344233||2020-08-24||⤷ Sign up for a Free Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|